Finance

Beta
Lists
ECG:NYSE
Everus Construction Group Inc
$160.10
+3.07%
(+4.77) 1D
$160.00
-0.06% (-0.10)
After hours
Closed: Jun 29, 4:00:03 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ECG...
Open
$155.54
High
$160.26
Low
$151.95
Mkt. cap
8.17B
Avg. vol.
600.41K
Volume
0.00
P/E ratio
36.65
52-wk high
$171.58
52-wk low
$60.78
EPS
$4.37
Shares outstanding
51.04M
No. of employees
9K
Open
$155.54
High
$160.26
Low
$151.95
Mkt. cap
8.17B
Avg. vol.
600.41K
Volume
0.00
P/E ratio
36.65
52-wk high
$171.58
52-wk low
$60.78
EPS
$4.37
Shares outstanding
51.04M
No. of employees
9K
News stories
From sources across the web
About Everus Construction Group Inc
CEO-
Employees9.4K
Founded2024
HeadquartersBismarck, North Dakota, United States
SectorConstruction
Websiteeverus.com
Analyst ratings
Based on 6 analysts giving stock ratings to ECG in the past 3 months
Buy
Buy
3
Hold
3
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ECG in the last 3 months.
Highest
Current $160.10
$185.00 (+15.55%)
Average
$164.83 (+2.95%)
Lowest
$141.00 (-11.93%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brent Thielman
Oppenheimer
Buy
Initiated
$185.00
+15.6%
05/28/2026
Manish Somaiya
Cantor Fitzgerald
Hold
Reiterated
$174.00
+8.7%
05/08/2026
Ian Zaffino
Oppenheimer
Buy
Reiterated
$180.00
+12.4%
05/07/2026
Sergey Glinyanov
Freedom Capital Markets
Hold
Downgraded
$157.00
-1.9%
05/07/2026
Joseph Osha
Guggenheim
Buy
Maintained
$160.00
-0.1%
05/06/2026
Brian Brophy
Stifel Nicolaus
Buy
Reiterated
$172.00
+7.4%
05/08/2026
Austin Wang
GLJ Research
Hold
Initiated
$141.00
-11.9%
04/20/2026
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$1.14 / $0.85
+34.65%beat
Revenue / Est. (USD)
1.04B / 936.90M
+10.68%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
921.47M
986.82M
1.01B
1.04B
Cost of goods sold
801.60M
862.60M
893.97M
906.22M
Cost of revenue
801.60M
862.60M
893.97M
906.22M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47.36M
51.84M
19.93M
53.04M
Operating expense
47.36M
51.84M
48.63M
53.04M
Total operating expenses
848.96M
914.44M
942.59M
959.27M
Operating income
72.51M
72.38M
68.88M
77.68M
Other non operating income
1.51M
3.44M
3.48M
799.00K
EBT including unusual items
72.25M
77.59M
73.99M
78.57M
EBT excluding unusual items
71.85M
77.29M
73.76M
78.82M
Income tax expense
19.41M
20.62M
18.71M
20.25M
Effective tax rate
26.86%
26.57%
25.29%
25.78%
Other operating expenses
-
-
-
-
Net income
52.84M
56.98M
55.28M
58.32M
Net profit margin
5.73%
5.77%
5.47%
5.62%
Earnings per share
1.03
1.11
1.08
1.14
Interest and investment income
-
1.37M
1.72M
2.32M
Interest expense
-4.81M
-5.44M
-5.01M
-4.62M
Net interest expenses
-4.81M
-4.07M
-3.30M
-2.30M
Depreciation and amortization charges
-
-
28.70M
-
EBITDA
79.63M
79.67M
76.37M
85.76M
Gain or loss from assets sale
-1.31M
-1.46M
-829.00K
-1.97M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer